A comprehensive national cell therapy research, development and testing platform that will benefit patients, healthcare providers, and industry
Joined February 2021
- Tweets 74
- Following 14
- Followers 30
- Likes 123
1 Photos and videos
27 Dec 2024
2024 - demolition complete
2025 - new year, new renovation, new science, new hope
@CDNCancerTrials @queensu @InnovationCA @KingstonHSC #SolvingCancerTogether
1
4
143
ExCELLirate Canada retweeted
10 Jun 2024
@queensu announced a $25M gift from Cara and Murray Sinclair to boost cancer research, build new facilities, and launch training programs. The Queen's Cancer Research Institute will be renamed the Cara & Murray Sinclair Cancer Research Institute (SCRI). queensu.ca/alumni/news/cance…
2
16
45
11,925
ExCELLirate Canada retweeted
12 Jun 2024
It was wonderful to welcome Cara and Murray Sinclair (Comm '84) to visit us on June 10th! Amazing people with a passion to make a difference for other families impacted by cancer. The beginning of a wonderful partnership with our cancer researchers @queensu @queensualumni
1
11
44
2,758
ExCELLirate Canada retweeted
13 Jun 2024
“Cell therapies are living drugs. It's a brand-new way of treating cancer.” @AnnetteHay1’s cutting-edge research bolstered by a $25M gift to @QueensuSCRI @QueensU. Learn how it will support the ultimate goal of a local biomanufacturing facility: bit.ly/45hemSV
3
15
1,333
ExCELLirate Canada retweeted
7 Aug 2023
Excited for us to bring this therapy to our patients with multiple myeloma @HamHealthSci @ECRI_RESEARCH @McMasteResearch @LabRullo @Balitsky_HemeMD @MyelomaCanada
7 Aug 2023
@CIHR_IRSC has announced $3,056,176 in funding over 5 years, for the TACtful trial investigating a novel cell therapy using the immune system to treat people with relapsed and refractory multiple #myeloma. @McMasteResearch #CCTG bit.ly/3OjqGtP
8
30
2,875
ExCELLirate Canada retweeted
15 Aug 2023
.@CIHR_IRSC funding announced for GCAR1 a Phase I feasibility & safety study of CAR T-cell therapy for patients with relapsed/refractory GPNMB-Expressing solid tumors. Dr Shafey, Dr Abdul Razak, Dr Hay, Dr Henning, Dr Kekre, Dr Mahoney, Dr Morrissy... bit.ly/3DUg8wm
3
1
8
771
ExCELLirate Canada retweeted
17 Aug 2023
Amazing. Bill, the new lab tech at QLMP is amazing us with his coverslipping skills and tissue-issue knowledge. We are humbled. @QueensPathology #histologypro
1
5
258
ExCELLirate Canada retweeted
20 Jul 2023
A HUGE CONGRATULATIONS to @AnnetteHay1 of our @QueensCRI @CDNCancerTrials division! @QueensUHealth healthsci.queensu.ca/stories…
1
6
17
1,698
ExCELLirate Canada retweeted
6 Apr 2023
Wow! Impressive data in @NEJM from our Italian colleagues at Bambino Gesu @bambinogesu in Rome. CART (with caspase 9 suicide gene) in Neuroblastoma: Overall response, 63%; 9 patients had a complete response, and 8 had a partial response. nejm.org/doi/pdf/10.1056/NEJ…
6
29
3,324
ExCELLirate Canada retweeted
14 Feb 2023
COMING SOON - New funding opportunity: The @cancersociety and our partners are proud to announce the inaugural Research Training Awards to build capacity in the cancer research ecosystem and support the next generation of researchers across Canada.
More details below.
1
10
27
4,242
ExCELLirate Canada retweeted
15 Feb 2023
Today we are getting “primed” to be BOND Masters. Thank you to our superb Leica Trainer! @LeicaBio @QueensPathology @CDNCancerTrials @excellirate @queensuResearch @CHI_CIS
3
8
694
ExCELLirate Canada retweeted
7 Feb 2023
Learning how to use the phenoimager and the science behind the optics and filters. Thanks Ladan for your patience with some of us newbies! @excellirate @AkoyaBio @CDNCancerTrials @QueensPathology
2
12
575
ExCELLirate Canada retweeted
2 Feb 2023
It’s Christmas in February! The amazing Akoya tech is here (literally all the way from Kalamazoo!) installing the new PhenoImager. Woo-hoo! @excellirate @CHI_CIS @CDNCancerTrials
3
7
996
1 Feb 2023
1 Feb 2023
Thanks to @CDNCancerTrials @excellirate @CHI_CIS our new BOND has arrived and is installed and ready for action!
2
100
ExCELLirate Canada retweeted
21 Nov 2022
CHOP researchers have published a three-year update of CAR T-cell therapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia in the ELIANA trial via @JCO_ASCO: bit.ly/3Axomtd.
12
12
ExCELLirate Canada retweeted
7 Nov 2022
And so it begins! Thanks to @InnovationCA @excellirate @OICR_news @KingstonHSC @QueensUHealth @CDNCancerTrials #radicalcollaboration #solvingcancertogether
1
4
18
ExCELLirate Canada retweeted
18 Oct 2022
Updated📢 Management of toxicities from #immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment & follow-up. W/ recommended assessment & tx algorithms according to grade of toxicity
ow.ly/K5nw50LcQyE
@HaanenJohn @wick_wolfgang @peters_solange @MarieKostine
1
123
251
ExCELLirate Canada retweeted
20 Sep 2022
20 Sep 2022
“We cannot control the winds, but we can adjust our sails to work together and keep moving in the right direction” - a fantastic sailing analogy by one of our esteemed speakers, Dr Annette Hay, Senior Investigator, CCTG - Excellirate.
#CGT #CellCAN #strategicforum2022
3
20
ExCELLirate Canada retweeted
New method from @harvardmed & @BostonChildrens could allow scaled-up production of generic cells for cancer immunotherapies: hms.harvard.edu/news/ready-m… #CancerResearch #Immunotherapy
4
5
ExCELLirate Canada retweeted
19 Jul 2022
19 Jul 2022
You can make CAR-T cells in one day if you wanted to. The technology is here. The current regulatory system will be the barrier. Not the science.
China will become the destination center. @NoopurRajeMD @DavidP4AD @kenderian_ss @Rfonsi1 @BloodCancerJnl nature.com/articles/s41408-0…
5
8